Clinical trial
Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to…
NCT00266214 · Endo Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00266214 |
|---|---|
| Title | Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome |
| Official title | A Randomized, Double-Blind Study Comparing the Safety and Efficacy of the Lidocaine Patch 5% With Placebo in Patients With Pain From Carpal Tunnel Syndrome |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carpal Tunnel Syndrome |
| Intervention type | Drug |
| Interventions | lidocaine patch 5% |
| Enrollment | 210 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Dec 16, 2005 |
| Last update posted | Jun 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: